Foresite Capital Opportunity Management V »

Kinnate Biopharma shares owned by Foresite Capital Opportunity Management V

Quarter-by-quarter ownership of Kinnate Biopharma shares owned by Foresite Capital Opportunity Management V from 13F filings

Historical chart of Foresite Capital Opportunity Management V investment in Kinnate Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Kinnate Biopharma held by Foresite Capital Opportunity Management V consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kinnate Biopharma by Foresite Capital Opportunity Management V

Quarter filed Position value Share count Share price at filing
2022-09-30 $3.5M 292k 11.95
2022-06-30 $3.7M 292k 12.61
2022-03-31 $3.3M 292k 11.26
2021-12-31 $5.2M 292k 17.72

More positions owned by Foresite Capital Opportunity Management V

Pardes Biosciences
Theseus Pharmaceuticals
Gemini Therapeutics
Compass Therapeutics (CMPX)
Kinnate Biopharma
Adicet Bio (ACET)
Quantum-Si Incorporated Com Cl A (QSI)
Hims & Hers Health Com Cl A (HIMS)
Enanta Pharmaceuticals (ENTA)

View all positions for Foresite Capital Opportunity Management V